TELA Bio Inc Ordinary Shares TELA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.51
- Day Range
- $2.39–2.49
- 52-Week Range
- $2.32–7.62
- Bid/Ask
- $1.99 / $2.71
- Market Cap
- $60.80 Mil
- Volume/Avg
- 47,860 / 215,597
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.93
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 0.02%
Company Profile
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 227
- Website
- https://www.telabio.com
Comparables
Valuation
|
Metric
|
TELA
|
FNA
|
SIBN
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 21.15 | 3.38 | 3.43 |
Price/Sales | 0.93 | 2.09 | 3.68 |
Price/Cash Flow | — | — | — |
Price/Earnings
TELA
FNA
SIBN
Financial Strength
|
Metric
|
TELA
|
FNA
|
SIBN
|
|---|---|---|---|
Quick Ratio | 2.37 | 1.63 | 7.99 |
Current Ratio | 3.41 | 3.57 | 9.17 |
Interest Coverage | −6.88 | −6.86 | −12.97 |
Quick Ratio
TELA
FNA
SIBN
Profitability
|
Metric
|
TELA
|
FNA
|
SIBN
|
|---|---|---|---|
Return on Assets (Normalized) | −57.28% | −17.60% | −6.03% |
Return on Equity (Normalized) | −210.35% | −31.66% | −8.10% |
Return on Invested Capital (Normalized) | −63.44% | −18.77% | −8.97% |
Return on Assets
TELA
FNA
SIBN
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Lqyvsqgdk | Qztfs | $197.7 Bil | |||
| Stryker Corp
SYK
| Jsscdqcp | Mxkj | $135.3 Bil | |||
| Boston Scientific Corp
BSX
| Jcltknvp | Xkvyxzr | $124.4 Bil | |||
| Medtronic PLC
MDT
| Bpsxmmdx | Gydhwh | $114.3 Bil | |||
| Edwards Lifesciences Corp
EW
| Qhkqhjlfgz | Vcsfhm | $39.2 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Frqc | Rqdz | $30.2 Bil | |||
| DexCom Inc
DXCM
| Mjnzylzyd | Jgtdx | $26.9 Bil | |||
| Steris PLC
STE
| Yxdpkxgg | Yjbgyz | $23.1 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Sljpqkvt | Kmxr | $21.5 Bil | |||
| Insulet Corp
PODD
| Yqjjgxkhcb | Lhtxp | $16.3 Bil |
United States